Deutsche Bank’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $201K | Buy |
44,927
+5,559
| +14% | +$27.8K | ﹤0.01% | 3002 |
|
|
2025
Q4 | $207K | Buy |
39,368
+2,303
| +6% | +$11.6K | ﹤0.01% | 2996 |
|
|
2025
Q3 | $196K | Hold |
37,065
| – | – | ﹤0.01% | 3073 |
|
|
2025
Q2 | $211K | Buy |
+37,065
| New | +$211K | ﹤0.01% | 2941 |
|
|
2023
Q3 | – | Sell |
-16,022
| Closed | -$64.6K | – | 3695 |
|
|
2023
Q2 | $64.6K | Hold |
16,022
| – | – | ﹤0.01% | 3421 |
|
|
2023
Q1 | $45.2K | Hold |
16,022
| – | – | ﹤0.01% | 3566 |
|
|
2022
Q4 | $49.3K | Hold |
16,022
| – | – | ﹤0.01% | 3582 |
|
|
2022
Q3 | $49K | Hold |
16,022
| – | – | ﹤0.01% | 3593 |
|
|
2022
Q2 | $83K | Hold |
16,022
| – | – | ﹤0.01% | 3599 |
|
|
2022
Q1 | $126K | Hold |
16,022
| – | – | ﹤0.01% | 3492 |
|
|
2021
Q4 | $135K | Hold |
16,022
| – | – | ﹤0.01% | 3564 |
|
|
2021
Q3 | $449K | Hold |
16,022
| – | – | ﹤0.01% | 3111 |
|
|
2021
Q2 | $625K | Sell |
16,022
-1,552
| -9% | -$63.3K | ﹤0.01% | 3077 |
|
|
2021
Q1 | $826K | Sell |
17,574
-147
| -0.8% | -$8.1K | ﹤0.01% | 2794 |
|
|
2020
Q4 | $696K | Buy |
17,721
+486
| +3% | +$16.6K | ﹤0.01% | 2687 |
|
|
2020
Q3 | $440K | Buy |
17,235
+115
| +0.7% | +$7.25K | ﹤0.01% | 2719 |
|
|
2020
Q2 | $1.25M | Buy |
17,120
+405
| +2% | +$28K | ﹤0.01% | 2076 |
|
|
2020
Q1 | $877K | Buy |
16,715
+244
| +1% | +$16.3K | ﹤0.01% | 2169 |
|
|
2019
Q4 | $1.34M | Buy |
16,471
+10,316
| +168% | +$728K | ﹤0.01% | 2208 |
|
|
2019
Q3 | $346K | Sell |
6,155
-12,736
| -67% | -$954K | ﹤0.01% | 2873 |
|
|
2019
Q2 | $2.25M | Buy |
18,891
+11,431
| +153% | +$1.92M | ﹤0.01% | 2319 |
|
|
2019
Q1 | $1.37M | Buy |
7,460
+23
| +0.3% | +$4.11K | ﹤0.01% | 2769 |
|
|
2018
Q4 | $1.33M | Sell |
7,437
-23,195
| -76% | -$5.06M | ﹤0.01% | 2681 |
|
|
2018
Q3 | $9.8M | Buy |
30,632
+4,227
| +16% | +$1.5M | 0.01% | 1652 |
|
|
2018
Q2 | $10.6M | Buy |
26,405
+13,095
| +98% | +$5.72M | 0.01% | 1698 |
|
|
2018
Q1 | $4.77M | Buy |
13,310
+7,857
| +144% | +$2.92M | ﹤0.01% | 2258 |
|
|
2017
Q4 | $2.16M | Sell |
5,453
-4,426
| -45% | -$1.83M | ﹤0.01% | 2668 |
|
|
2017
Q3 | $4.21M | Buy |
9,879
+8,764
| +786% | +$2.36M | ﹤0.01% | 2022 |
|
|
2017
Q2 | $177K | Buy |
+1,115
| New | +$152K | ﹤0.01% | 3989 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4870 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4880 |
|
|
2016
Q3 | – | Sell |
-521
| Closed | -$50.9K | – | 4882 |
|
|
2016
Q2 | $30K | Buy |
521
+453
| +666% | +$31K | ﹤0.01% | 4616 |
|
|
2016
Q1 | $4K | Sell |
68
-45
| -40% | -$2.98K | ﹤0.01% | 4973 |
|
|
2015
Q4 | $9K | Sell |
113
-13
| -10% | -$1.3K | ﹤0.01% | 4935 |
|
|
2015
Q3 | $12K | Buy |
126
+27
| +27% | +$3.58K | ﹤0.01% | 4905 |
|
|
2015
Q2 | $12K | Buy |
+99
| New | +$14.9K | ﹤0.01% | 5018 |
|
Other funds holding ABEO
NCM
ACM
CCC
SCM
VCM
PBM
KCM
Deutsche Bank's ABEO Position: Q1 2026 in Review
Deutsche Bank increased its Abeona Therapeutics (ABEO) stake by 14% in Q1 2026, buying an estimated $27.8K and bringing the position to 44,927 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #3002.
Deutsche Bank first reported a position in ABEO in Q2 2015 and has held it in 34 quarters since. The position peaked at $10.6M in Q2 2018. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.
- Deutsche Bank held 44,927 shares of Abeona Therapeutics worth $201K as of Q1 2026.
- Deutsche Bank bought 5,559 Abeona Therapeutics shares in Q1 2026, an estimated $27.8K.
- Abeona Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3002 holding.
- Deutsche Bank first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 34 quarters since.
- Deutsche Bank's Abeona Therapeutics position peaked at $10.6M in Q2 2018.
- 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.